In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.

SBRT showed improved LPFS over RFA in treating single recurrent small HCC, especially for tumors ≤2 cm. Both SBRT and RFA demonstrated similar PFS, OS, and safety profiles, with mild to moderate side ...

The median radiographic progression-free survival was 4.6 years in patients who received stereotactic body radiotherapy and 2.3 years in patients who did not. Adding metastasis-directed stereotactic ...

The primary end points were FISST and local control (LC) rates of lesions that received SBRT. The secondary end point was overall survival (OS) after SBRT. To calculate FISST, event was defined as the ...

The American Society for Radiation Oncology (ASTRO) has issued new guidelines on the appropriate use of stereotactic radiation (SBRT) in early-stage non-small cell lung cancer (NSCLC), now the leading ...

Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...

Please provide your email address to receive an email when new articles are posted on . The number of facilities prescribing single-fraction lung SBRT is gradually growing, yet primarily at ...

Please provide your email address to receive an email when new articles are posted on . Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among ...

Maastricht, the Netherlands - A new technique using urokinase to liquefy intracerebral hematoma (ICH) followed by stereotactic drainage is safe and produced a "modest" reduction in the amount of ...

Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma In this trial, patients with recurrent small HCC (single lesion ≤5 cm) were randomly assigned to receive either SBRT or RFA.